Stevanato Group to Present at Upcoming Investor Conferences
11 Novembre 2024 - 12:32PM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment and delivery solutions to the pharmaceutical,
biotechnology, and life sciences industries, announced today that
it will participate in three upcoming investor conferences.
The Company will participate in a fireside chat at the UBS
Global Healthcare Conference in Rancho Palos Verdes, California on
Tuesday, November 12, 2024 at 11:00 a.m. (PT). The Company will
also present at the Jefferies London Healthcare Conference on
Tuesday, November 19, 2024 at 9:00 a.m. (GMT), and the Citi 2024
Global Healthcare Conference in Miami on Tuesday, December 3, 2024
at 1:45 p.m. (ET). A live webcast of each event will be available
on the Company’s website at www.stevanatogroup.com under the
"Investors" section. Replays of the webcasts will be available for
approximately 90 days after each event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients. To learn more,
visit: www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241111945147/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Grafico Azioni Stevanato (NYSE:STVN)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Stevanato (NYSE:STVN)
Storico
Da Dic 2023 a Dic 2024